Theoretically, RAC could have amazingly bad luck and only recruit patients with the cancer cell lines that show no improvement in combo with dox.
The insurance against this is proof of concept of CP would progress the trial forward long enough to push past any statistical outliers.
That is definitely glass half empty pragmatism. Knowing these preclinical results have over 4/5ths of tested cell lines having positive synergy in combo with dox is glass mostly full optimism.
I anticipate early read outs with proof/failure of concept before years end (CY).
RAC
race oncology ltd
Add to My Watchlist
1.27%
!
$1.20

General Comments / Chat, page-12786
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.20 |
Change
0.015(1.27%) |
Mkt cap ! $208.4M |
Open | High | Low | Value | Volume |
$1.20 | $1.20 | $1.17 | $139.7K | 118.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 666 | $1.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.20 | 7691 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1538 | 1.180 |
3 | 22097 | 1.170 |
2 | 10853 | 1.160 |
3 | 30900 | 1.150 |
7 | 13634 | 1.140 |
Price($) | Vol. | No. |
---|---|---|
1.200 | 7691 | 3 |
1.210 | 9169 | 2 |
1.220 | 2000 | 1 |
1.225 | 4043 | 2 |
1.230 | 2100 | 1 |
Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online